Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
de Bruijne J, Buster EH, Gelderblom HC, Brouwer JT, de Knegt RJ, van Erpecum KJ, Schalm SW, Bakker CM, Zaaijer HL, Janssen HL, Reesink HW; Netherlands Association of Gastroenterologists and Hepatologists. de Bruijne J, et al. Among authors: van erpecum kj. Neth J Med. 2008 Jul-Aug;66(7):311-22. Neth J Med. 2008. PMID: 18663263 Free article. Review.
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study).
Farag MS, van Campenhout MJH, Sonneveld MJ, Fung S, van Erpecum KJ, Wong DK, Verhey E, de Man R, De Knegt RJ, Brouwer JT, Baak HC, Feld JJ, Liem KS, Boonstra A, Hansen BE, Janssen HLA. Farag MS, et al. Among authors: van erpecum kj. J Viral Hepat. 2024 Apr;31(4):197-207. doi: 10.1111/jvh.13918. Epub 2024 Jan 19. J Viral Hepat. 2024. PMID: 38243144 Clinical Trial.
Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease.
van Dijk AM, de Vries M, El-Morabit F, Bac ST, Mundt MW, van der Schuit LE, Hirdes MMC, Kara M, de Bruijne J, van Meer S, Kaasjager HAH, de Valk HW, Vleggaar FP, van Erpecum KJ. van Dijk AM, et al. Among authors: van erpecum kj. Intern Emerg Med. 2023 Nov;18(8):2271-2280. doi: 10.1007/s11739-023-03417-2. Epub 2023 Sep 12. Intern Emerg Med. 2023. PMID: 37700180 Free PMC article.
Health-related quality of life in patients with primary sclerosing cholangitis: A longitudinal population-based cohort study.
Mol B, van Munster KN, Bogaards JA, Weersma RK, Inderson A, de Groof EJ, Rossen NGM, Ponsioen W, Turkenburg M, van Erpecum KJ, Poen AC, Spanier BWM, Beuers UHW, Ponsioen CY; EpiPSC2 study group. Mol B, et al. Among authors: van erpecum kj. Liver Int. 2023 May;43(5):1056-1067. doi: 10.1111/liv.15542. Epub 2023 Feb 28. Liver Int. 2023. PMID: 36779848
Disease burden in primary sclerosing cholangitis in the Netherlands: A long-term follow-up study.
van Munster KN, Mol B, Goet JC, van Munster SN, Weersma RK, de Vries AC, van der Meer AJ, Inderson A, Drenth JP, van Erpecum KJ, Boonstra K, Beuers U, Dijkgraaf MGW, Ponsioen CY; EpiPSC2 Study Group. van Munster KN, et al. Among authors: van erpecum kj. Liver Int. 2023 Mar;43(3):639-648. doi: 10.1111/liv.15471. Epub 2022 Nov 15. Liver Int. 2023. PMID: 36328957
273 results